Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Kelsey Miller 2016. MojoSort™ Nanobeads Regular Protocol. protocols.io https://dx.doi.org/10.17504/protocols.io.e2sbgeeCopy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.e2sbgee
Authors: Kelsey Miller
Group: BioLegend
Summary: The cells targeted by the Nanobeads are either selected or depleted by incubating your sample with the directly conjugated magnetic particles. The magnetically labeled fraction is retained by the use of a magnetic separator. After collection of the targeted cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc.Note: For Human CD4 Nanobeads, please refer to the protocol found on the product webpage for MojoSort™ Human CD4 Nanobeads (Cat. No. 480013/480014).
Affiliations: BioLegend
External URL: http://www.biolegend.com/media_assets/support_protocol/MojoSort_Nanobeads_Regular_Protocol_V02_10192015.pdf
Version: 1
Publication Date: 2016
Expand AllComing soon.
Source: